These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 782102)

  • 1. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man.
    Couch RB; Douglas RG; Fedson DS; Kasel JA
    J Infect Dis; 1971 Nov; 124(5):473-80. PubMed ID: 5000515
    [No Abstract]   [Full Text] [Related]  

  • 2. Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells.
    Frensing T; Kupke SY; Bachmann M; Fritzsche S; Gallo-Ramirez LE; Reichl U
    Appl Microbiol Biotechnol; 2016 Aug; 100(16):7181-92. PubMed ID: 27129532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of species and organ-specific features of tissue systems on the reactogenic and immunogenic properties of influenza virus.
    Gorev NE
    Acta Virol; 1975 Jan; 19(1):41-6. PubMed ID: 235196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees.
    Leibovitz A; Coultrip RL; Kilbourne ED; Legters LJ; Smith CD; Chin J; Schulman JL
    J Infect Dis; 1971 Nov; 124(5):481-7. PubMed ID: 5115671
    [No Abstract]   [Full Text] [Related]  

  • 5. [Latent influenza infection, the new type of viral persistence].
    Zuev VA
    Vestn Akad Med Nauk SSSR; 1973; 28(2):3-16. PubMed ID: 4774032
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methodical principles for improving influenza vaccines].
    Sokolov NN; Sumarokov AA; Perepelkin VS
    Zh Mikrobiol Epidemiol Immunobiol; 1976 May; (5):3-9. PubMed ID: 782102
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiplication of myxoviruses.
    Rott R; Scholtissek C
    Mod Trends Med Virol; 1967; 1(0):25-48. PubMed ID: 4950641
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure and replication of alpha-viruses.
    Kääriäinen L; Söderlund H
    Curr Top Microbiol Immunol; 1978; 82():15-69. PubMed ID: 365471
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results and prospects for vaccinal prevention of influenza].
    Smorodintsev AA; Aleksandrova GI
    Vopr Virusol; 1977; (3):259-71. PubMed ID: 333765
    [No Abstract]   [Full Text] [Related]  

  • 10. [Host antigens in the structure of influenza viruses].
    Fridman EA; Bokhnevich GM
    Tr Inst Im Pastera; 1976; 47():167-73. PubMed ID: 80046
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of vaccines for pandemic influenza H5N1.
    Pareek M; Stephenson I
    Br J Hosp Med (Lond); 2007 Feb; 68(2):80-4. PubMed ID: 17370705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making better influenza virus vaccines?
    Palese P
    Emerg Infect Dis; 2006 Jan; 12(1):61-5. PubMed ID: 16494719
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.